Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
32.61
-1.94 (-5.62%)
Feb 4, 2026, 2:27 PM EST - Market open
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $1.58 billion as of February 4, 2026. Its market cap has increased by 268.21% in one year.
Market Cap
1.58B
Enterprise Value
1.11B
1-Year Change
268.21%
Ranking
Category
Stock Price
$32.61
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $1.58B, an increase of 85.87%. That is a compound annual growth rate of 54.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.67B | 13.99% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.73B |
| Precigen | 1.70B |
| Tango Therapeutics | 1.69B |
| Celldex Therapeutics | 1.67B |
| Upstream Bio | 1.67B |
| Tyra Biosciences | 1.67B |
| Monte Rosa Therapeutics | 1.66B |
| Enliven Therapeutics | 1.64B |